As Panadol marks 70 years, Haleon is launching Panadol Baby & Infant in Egypt, opening a new chapter for the brand. For Asif Alavi, general manager of Haleon North Africa, the milestone is about helping families make informed health decisions with confidence.
Panadol has been part of family healthcare for generations, with parents who grew up with the brand now choosing it for their own children. “Panadol’s 70-year global legacy reflects decades of consistent quality, science, and a continued focus on the evolving health needs of people around the world,” Alavi says. The launch of Panadol Baby & Infant builds on this heritage while responding to the needs of babies and infants.
For parents, the practical question is more immediate: what is right for their child? “When a baby is unwell, parents want a solution designed for their child’s age and weight, with clear instructions they can follow,” Alavi explains. Panadol Baby & Infant is designed to meet that need, bringing the familiarity of the Panadol name to the youngest members of Egyptian families.
That launch is part of Haleon’s longer-term commitment to Egypt and its communities. Guided by its purpose of delivering better everyday health with humanity, the company works with pharmacists and healthcare professionals to raise awareness of responsible self-care, helping people understand what they can manage themselves and when professional medical care is needed.
Responsible self-care can also strengthen health systems. Global Self-Care Federation research (pdf) estimates that self-care saves health systems USD 144 bn a year globally and frees around 2.2 bn hours of physicians’ time. By enabling people to safely manage minor, common conditions, it can help preserve healthcare resources for patients who need clinical attention most.